Search the Newsreel

Morgan Stanley Adjusts Agilent Technologies PT to $175 From $160, Maintains Overweight Rating

Morgan Stanley has increased its price target for Agilent Technologies (A) to $175, up from $160, while reiterating an Overweight rating on the stock. This adjustment reflects a positive outlook for the company's financial performance and market position.

AQR Capital discloses 4.15% agilon health (AGL) stake in Schedule 13G/A

AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a beneficial ownership of 4.15% in agilon health, inc. (AGL) common stock through a Schedule 13G/A filing. This stake amounts to 692,541 shares, with shared voting power over 666,033 shares …

Wasatch Advisors LP Reduces Position in Agilysys, Inc. $AGYS

Wasatch Advisors LP reduced its stake in Agilysys, Inc. by 1.7% in the second quarter, selling 16,310 shares but still holding 937,420 shares valued at $98 million. Agilysys reported better-than-expected quarterly revenue of $87.68 million and earnings of $0.49 per share, marking a 14.3% …

5 Insightful Analyst Questions From agilon health’s Q2 Earnings Call

agilon health (AGL) significantly beat revenue and profitability estimates in Q2, though its share price dropped. Management attributed strong financials to operational improvements and AI investments. Analysts questioned the sustainability of improved medical margins, seasonality in cost trends, and the sources of medical cost …

Agilent Technologies Inc (A) Scores 97/100 on GF Score: A High-Q

Agilent Technologies Inc (A) has achieved an exceptional GF Score of 97 out of 100, indicating a high potential for market outperformance. This score is driven by strong rankings in financial strength (7/10), profitability (9/10), growth (10/10), GF Value (9/10), and momentum (8/10). The …

Agilent’s OpenLab Sync Supports Guided, Digital Laboratory Execution

Agilent Technologies Inc. has launched OpenLab Sync, a new Lab Execution System (LES) designed to digitalize scientific workflows from method design to execution in laboratories. This system aims to enhance consistency, data integrity, and audit readiness in regulated environments by offering guided, digital workflows …

AGILON HEALTH, INC. : CITIGROUP RAISES TO NEUTRAL FROM SELL; RAISES TARGET PRICE TO $115 FROM $105

Citigroup has upgraded its rating for Agilon Health, Inc. from "Sell" to "Neutral" and simultaneously increased its target price for the company's stock to $115 from $105. This adjustment reflects a more optimistic outlook on Agilon Health's financial prospects by the analyst firm. The …

Agilysys, Inc. $AGYS Shares Sold by Janus Henderson Group PLC

Janus Henderson Group PLC significantly reduced its stake in Agilysys, Inc. (AGYS) by 81.9% in the first quarter, selling over 53,000 shares. Despite this institutional selling and recent insider sales by CEO Ramesh Srinivasan and other insiders, analysts maintain a "Moderate Buy" rating with …

AGILYSYS INC : NEEDHAM RAISES TARGET PRICE TO $135 FROM $130

Needham has raised its target price for Agilysys Inc. (AGYS) shares to $135 from $130. This update reflects an analyst's revised valuation for the company. The article, sourced from Reuters, provides this key financial news.

Needham raises Agilysys stock price target on Marriott rollout

Needham has increased its price target for Agilysys Inc (NASDAQ:AGYS) to $135 from $130, maintaining a Buy rating, following investor meetings and the company's strong performance, including the rollout of its property management system at over 2,000 Marriott hotels. Agilysys reported record bookings and …

Needham & Company LLC Issues Positive Forecast for Agilysys (NASDAQ:AGYS) Stock Price

Needham & Company LLC has raised its price target for Agilysys (NASDAQ:AGYS) to $135 from $130, maintaining a "buy" rating and implying a potential upside of 24.33%. This comes after Agilysys surpassed quarterly earnings and revenue expectations. Despite significant insider selling, institutional investors hold …

Projeções de Resultados: Agilent Technologies Inc (A) — LPA e Crescimento de Receita

Agilon Health Earnings Call Signals Profitable Turnaround

Agilon Health's Q2 earnings call revealed a significant financial turnaround with revenue up 7.1% year-over-year to $1.5 billion and medical margin swinging from a loss to a positive $197 million. The company raised its full-year 2026 revenue guidance to $5.8 billion and adjusted EBITDA …

agilon Health (AGL) Could Be 22% Overvalued On Its Profit Turn And Outlook Raise

agilon health (AGL) reported strong Q2 results, shifting from a net loss to profit and raising its full-year 2026 revenue guidance. Despite a significant recent share price rebound, Simply Wall St's analysis suggests the stock might be 22.2% overvalued at $95.51 compared to a …

Will Strong Q1 Results and Higher Guidance Change Agilysys' (AGYS) Operating Leverage Narrative?

Agilysys, Inc. reported strong first-quarter 2026 results with higher revenue and net income, alongside raised fiscal 2027 revenue and subscription growth guidance, indicating increased operating leverage in its hospitality software model. This performance supports the company's long-term thesis of a shift to cloud and …

TD Cowen Maintains Agilon Health(AGL.US) With Hold Rating, Raises Target Price to $95

TD Cowen has reiterated its Hold rating on Agilon Health (AGL.US) and increased its target price to $95. This indicates a continued neutral stance on the stock with a slightly more optimistic outlook on its valuation.

PensionDanmark Pensionsforsikringsaktieselskab Increases Stake in Agilent Technologies, Inc. $A

PensionDanmark Pensionsforsikringsaktieselskab increased its stake in Agilent Technologies, Inc. by 9.6% during the second quarter, adding 7,371 shares to its holdings, now valued at approximately $11.1 million. Analysts maintain a "Moderate Buy" rating with a consensus target price of $159.35. Agilent Technologies exceeded quarterly …

Agilysys CEO Ramesh Srinivasan sells $21.3m in company stock

Agilysys CEO Ramesh Srinivasan sold 197,410 shares of company stock between August 5 and August 7, 2026, totaling approximately $21.3 million. Following these transactions, Srinivasan directly holds 610,044 shares and indirectly holds 60,000 shares. This comes after Agilysys reported strong fiscal first-quarter results for …

Agilysys, Inc. (NASDAQ:AGYS) Receives Consensus Rating of "Moderate Buy" from Analysts

Agilysys, Inc. (NASDAQ:AGYS) has received a "Moderate Buy" consensus rating from eight research firms, with an average 12-month price target of $123.60, indicating potential upside from its current price. The company recently exceeded Q1 earnings and revenue expectations, though insiders have sold a significant …

Agilysys Inc (AGYS) Stock News Today

This article provides current stock information for Agilysys Inc (AGYS), including its market cap, P/E ratio, and recent stock performance. It notes that more news is expected soon regarding earnings, analyst ratings, and key developments for the company.

Agilon Health (AGL) Stock Price Drops Despite Sharp Margin Rebound

Agilon Health (AGL) experienced a significant stock price drop despite reporting a sharp rebound in medical margin and returning to profitability in Q2 2026. The company posted US$1.5 billion in revenue and achieved a medical margin of US$197 million, along with US$70 million in …

Agilysys (NASDAQ: AGYS) holder files to sell 25,000 shares under Form 144

Ramesh Srinivasan and Sujatha Srinivasan, joint tenants, have filed a Form 144 to sell up to 25,000 shares of Agilysys (AGYS) common stock through Morgan Stanley Smith Barney LLC on August 7, 2026. These shares originated from restricted stock that vested on June 10, …

Agilysys (AGYS) CEO sells 197,410 shares in multi-day stock sales

Agilysys (AGYS) CEO Ramesh Srinivasan sold a total of 197,410 common shares in open market or private transactions between August 5 and August 7, 2026. The sales were executed

CEO equity awards at Agilysys Inc (AGYS) tied to $105–$135 stock goals

Agilysys Inc. has granted its President & CEO, Ramesh Srinivasan, 78,270 Restricted Stock Units (RSUs) in two equal awards on June 18, 2026. One portion of 39,135 units is time-based, vesting from June 2028, while the other 39,135 units are performance-based, vesting only if …

Agilent Technologies, Inc. (NYSE:A) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Agilent Technologies, Inc. (NYSE:A) has received a "Moderate Buy" consensus rating from 19 brokerages, with an average 12-month price target of $159.35, exceeding its current share price. The company recently surpassed quarterly earnings expectations with $1.49 EPS and $1.83 billion in revenue, representing a …

Can agilon health (AGL) Justify Its Valuation As Earnings Turned Profitable?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Why agilon health stock is in focus after the latest earnings agilon health (AGL) is back on investors' radar after second quarter results showed a shift from …

agilon health, inc. Stock 12‑Month Price Target Raised to $106.69, Implies 1% Downside

agilon health, inc.'s average stock price target has been raised from $85.92 to $106.69 by 13 analysts, with a range of $31 to $141 per share. This updated target suggests a 1% potential downside based on the August 5th closing price. The consensus rating …

agilon health, inc. (AGL) stock price, news, quote and history

This page provides comprehensive information on agilon health, inc. (AGL) stock, including its current price, historical data, news, and financial analysis. It details key statistics like market cap, PE ratio, and earnings date, alongside performance comparisons with the S&P 500. The article also includes …

Agilent Technologies Inc. stock outperforms competitors on strong trading day

Agilent Technologies Inc. stock (A) saw a significant rise of 3.28% to $145.97 on Friday, outperforming the broader market indices like the S&P 500 and Dow Jones Industrial Average. This marked the third consecutive day of gains for the stock. The positive performance occurred …

Royal Bank of Canada Has $17.54 Million Holdings in Agilysys, Inc. $AGYS

Royal Bank of Canada decreased its stake in Agilysys, Inc. by 13.5% in the first quarter, now holding 246,588 shares valued at $17.54 million. Despite this reduction, institutional investors collectively own about 88% of Agilysys, which recently surpassed earnings and revenue expectations with a …

Agilon Health Inc (AGL) News, Articles, Events & Latest Updates

Agilon Health (AGL) recently reported strong Q2 2026 earnings, exceeding revenue and EPS estimates, and increased its full-year guidance for total revenues, medical margin, and adjusted metrics. The company also announced significant savings from its ACO REACH Model for the 2024 performance year. However, …

Agilent Technologies (A) Secures Expanded EU Approval For Ovarian Cancer Test

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Agilent Technologies (NYSE:A) secured expanded European approval for its PD-L1 IHC 22C3 pharmDx test for ovarian cancer applications. The CE-marked indication now covers patients with ovarian, fallopian …

Agilysys (AGYS) holder files to resell 40,000 vested shares

A shareholder of Agilysys, Inc. (AGYS) has filed a Form 144 to sell up to 40,000 shares of common stock through Morgan Stanley Smith Barney LLC. These shares were acquired via restricted stock vesting on June 10, 2021, and the planned sale date reference …

Agilysys (AGYS) insider Ramesh Srinivasan files to sell 66,205 shares

Agilysys insider Ramesh Srinivasan has filed a Form 144 notice to sell 66,205 common shares of Agilysys, Inc. The shares, valued at approximately $7.06 million, are scheduled for sale on or after August 6, 2026, through Fidelity Brokerage Services LLC on NASDAQ. These shares …

Agilent Premieres 1290 Infinity III Fluorescence Detector

Agilent Technologies Inc. has launched the Agilent 1290 Infinity III Fluorescence Detector (FLD), designed to extend fluorescence detection capabilities into modern ultra-high-performance liquid chromatography (UHPLC) workflows. This new detector offers ultra-trace sensitivity, UHPLC-ready chromatographic performance, and ease of use, making it suitable for standalone …

Navigating Alphabet’s (GOOGL) AI Frontier

Bronte Capital, an investment management company, released its "Amalthea Fund" second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Fund posted a 6.49% net return in June, bringing the quarterly returns to 5.12%, compared to 3.17% and 14.48% for …